Aimee Yu
Pulmonary Disease · Annapolis, MDNPI 1982603940
Payments from drug & device makers
Across 98 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$388
- AstraZeneca$361
- Sanofi$276
- GSK$232
- Insmed, Inc.$156
- Mallinckrodt Enterprises LLC$142
- plus $507 from 15 others
What the payments were for
- Food & beverage$2,061100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 20 | $388 |
| AstraZeneca | 17 | $361 |
| Sanofi | 8 | $276 |
| GSK | 12 | $232 |
| Insmed, Inc. | 11 | $156 |
| Mallinckrodt Enterprises LLC | 3 | $142 |
| Grifols USA, LLC | 5 | $98 |
| Mylan Specialty L.p. | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Philips North America LLC | 2 | $45 |
| Genentech USA, Inc. | 2 | $44 |
| Paratek Pharmaceuticals, Inc. | 2 | $43 |
| Electromed, Inc. | 2 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $33 |
| Merck | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Novartis | 1 | $18 |
| Harmony Biosciences LLC | 1 | $17 |
| AbbVie | 1 | $16 |
| Advanced Respiratory, Inc | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,061 in reported general payments places this provider in the 55th percentile of 297 pulmonary disease providers in Maryland.
Other pulmonary disease in Annapolis
- Richard BernsteinAnnapolis$5.7M
- Alan SchwartzBaltimore$1.6M
- Sonye DanoffBaltimore$1.5M
- Michael DrummondBaltimore$1.4M
- da Wei LiaoBethesda$1.3M
- Paul HassounBaltimore$1.3M
- Lonny YarmusBaltimore$1.2M
- Jonathan SevranskyBaltimore$971K
- Robert ChasseSalisbury$788K
- Robert WiseBaltimore$761K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.